<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Kidney failure</title><meta name="description" content="Kidney failure, also known as renal failure or end-stage renal disease (ESRD), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels.[2] Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible.[6] Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite,..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="keywords" content="Renal failure, Acute kidney injury, End-stage renal disease, ESRD"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Kidney_failure"/><meta property="og:title" content="Kidney failure"/><meta property="og:description" content="Kidney failure, also known as renal failure or end-stage renal disease (ESRD), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels.[2] Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible.[6] Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite,..."/><meta property="og:url" content="https://grokipedia.com/page/Kidney_failure"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Kidney failure"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:12.986Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Kidney failure"/><meta name="twitter:description" content="Kidney failure, also known as renal failure or end-stage renal disease (ESRD), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels.[2] Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible.[6] Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite,..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="6e267ee5003d799791a59bffb04a8043-a6afeff61a80b30f-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=6e267ee5003d799791a59bffb04a8043,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.8686182497527326,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#kidney-failure" class="transition-opacity hover:opacity-100 opacity-50">Kidney failure</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#classification" class="transition-opacity hover:opacity-100 opacity-50">Classification</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#acute-kidney-failure" class="transition-opacity hover:opacity-100 opacity-50">Acute kidney failure</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#chronic-kidney-failure" class="transition-opacity hover:opacity-100 opacity-50">Chronic kidney failure</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#acute-on-chronic-kidney-failure" class="transition-opacity hover:opacity-100 opacity-50">Acute-on-chronic kidney failure</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#signs-and-symptoms" class="transition-opacity hover:opacity-100 opacity-50">Signs and symptoms</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#causes-of-kidney-failure" class="transition-opacity hover:opacity-100 opacity-50">Causes of Kidney Failure</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#acute-kidney-injury" class="transition-opacity hover:opacity-100 opacity-50">Acute kidney injury</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#chronic-kidney-failure-1" class="transition-opacity hover:opacity-100 opacity-50">Chronic kidney failure</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#genetic-predisposition" class="transition-opacity hover:opacity-100 opacity-50">Genetic predisposition</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#diagnostic-approach" class="transition-opacity hover:opacity-100 opacity-50">Diagnostic approach</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#measurement-for-ckd" class="transition-opacity hover:opacity-100 opacity-50">Measurement for CKD</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#stages-of-chronic-kidney-disease" class="transition-opacity hover:opacity-100 opacity-50">Stages of chronic kidney disease</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#glomerular-filtration-rate" class="transition-opacity hover:opacity-100 opacity-50">Glomerular filtration rate</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#complications" class="transition-opacity hover:opacity-100 opacity-50">Complications</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#treatment" class="transition-opacity hover:opacity-100 opacity-50">Treatment</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#diet" class="transition-opacity hover:opacity-100 opacity-50">Diet</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#slowing-progression" class="transition-opacity hover:opacity-100 opacity-50">Slowing progression</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="kidney-failure" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Kidney failure<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Kidney failure</strong>, also known as <strong>renal failure</strong> or <strong>end-stage renal disease</strong> (<strong>ESRD</strong>), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Complications of acute and chronic failure include uremia, hyperkalemia, and volume overload.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Complications of chronic failure also include heart disease, high blood pressure, and anemia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Causes of acute kidney failure include low blood pressure, blockage of the urinary tract, certain medications, muscle breakdown, and hemolytic uremic syndrome.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_21abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Causes of chronic kidney failure include diabetes, high blood pressure, nephrotic syndrome, and polycystic kidney disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_41abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Diagnosis of acute failure is often based on a combination of factors such as decreased urine production or increased serum creatinine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_61abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Diagnosis of chronic failure follows guidelines such as KDIGO 2024, based on a glomerular filtration rate (GFR) of less than 15 mL/min/1.73 mÂ² or the need for renal replacement therapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> It is also equivalent to stage 5 chronic kidney disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Treatment of acute failure depends on the underlying cause.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_21qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> Treatment of chronic failure may include hemodialysis, peritoneal dialysis, or a kidney transplant.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_41qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Hemodialysis uses a machine to filter the blood outside the body.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_61qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> In peritoneal dialysis specific fluid is placed into the abdominal cavity and then drained, with this process being repeated multiple times per day.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Kidney transplantation involves surgically placing a kidney from someone else and then taking immunosuppressant medication to prevent rejection.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Other recommended measures for chronic disease include staying active and specific dietary changes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Depression is also common among patients with kidney failure, and is associated with poor outcomes including higher risk of kidney function decline, hospitalization, and death. A 2019 PCORI-funded study of patients with kidney failure receiving outpatient hemodialysis found similar effectiveness between nonpharmacological and pharmacological treatments for depression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the United States, acute failure affects about 3 per 1,000 people a year.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_22abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> Chronic failure affects about 2 in 1,000 people, with approximately 4 per 10,000 people newly developing the condition each year (as of 2022).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_42abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> In Canada, the lifetime risk of kidney failure or end-stage renal disease (ESRD) was estimated to be 2.66% for men and 1.76% for women.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_62abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Acute failure is often reversible while chronic failure often is not.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_82abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> With appropriate treatment many with chronic disease can continue working.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<h1 id="classification" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Classification<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Kidney failure can be divided into two categories: <span class="inline text-[1em] leading-7">acute kidney failure</span> or <span class="inline text-[1em] leading-7">chronic kidney failure</span>. The type of renal failure is differentiated by the trend in the serum <span class="inline text-[1em] leading-7">creatinine</span>; other factors that may help differentiate acute kidney failure from chronic kidney failure include <span class="inline text-[1em] leading-7">anemia</span> and the kidney size on <span class="inline text-[1em] leading-7">sonography</span> as chronic kidney disease generally leads to anemia and small kidney size.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></span>
<h3 id="acute-kidney-failure" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Acute kidney failure<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Acute kidney injury</span> (AKI), previously called acute renal failure (ARF),<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_34abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_44abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> is a rapidly progressive loss of <span class="inline text-[1em] leading-7">renal function</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> generally characterized by <span class="inline text-[1em] leading-7">oliguria</span> (decreased <span class="inline text-[1em] leading-7">urine</span> production, quantified as less than 400 <span class="inline text-[1em] leading-7">mL</span> per day in adults,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup> less than 0.5 mL/kg/h in children or less than 1 mL/kg/h in infants); and <span class="inline text-[1em] leading-7">fluid and electrolyte imbalance</span>. AKI can result from a variety of causes, generally classified as <em>prerenal</em> , <em>intrinsic</em> , and <em>postrenal</em>. Many people diagnosed with <span class="inline text-[1em] leading-7">paraquat intoxication</span> experience AKI, sometimes requiring <span class="inline text-[1em] leading-7">hemodialysis</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_u4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> The underlying cause must be identified and treated to arrest the progress, and <span class="inline text-[1em] leading-7">dialysis</span> may be necessary to bridge the time gap required for treating these fundamental causes.</span>
<h3 id="chronic-kidney-failure" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Chronic kidney failure<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Chronic kidney disease</span> (CKD) can also develop slowly and, initially, show few symptoms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_35abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> CKD can be the long term consequence of irreversible acute disease or part of a disease progression. CKD is divided into five stages (1â€“5) based on the estimated glomerular filtration rate (eGFR). Stage 1 is defined by eGFR â‰¥90 mL/min/1.73 mÂ² with evidence of kidney damage. Stage 5 (also known as end-stage renal disease) is defined by eGFR &lt;15 mL/min/1.73 mÂ² or the need for renal replacement therapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_55abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup></span>
<h3 id="acute-on-chronic-kidney-failure" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Acute-on-chronic kidney failure<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Acute kidney injuries can be present on top of chronic kidney disease, a condition called acute-on-chronic kidney failure (AoCRF). The acute part of AoCRF may be reversible, and the goal of treatment, as with AKI, is to return the person to baseline kidney function, typically measured by serum <span class="inline text-[1em] leading-7">creatinine</span>. Like AKI, AoCRF can be difficult to distinguish from chronic kidney disease if the person has not been monitored by a <span class="inline text-[1em] leading-7">physician</span> and no baseline (i.e., past) blood work is available for comparison.</span>
<h2 id="signs-and-symptoms" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Signs and symptoms<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Symptoms can vary from person to person. Someone in early stage kidney disease may not feel sick or notice symptoms as they occur. When the kidneys fail to filter properly, waste accumulates in the blood and the body, a condition called <span class="inline text-[1em] leading-7">azotemia</span>. Very low levels of azotemia may produce few, if any, symptoms. If the disease progresses, symptoms become noticeable (if the failure is of sufficient degree to cause symptoms). Kidney failure accompanied by noticeable symptoms is termed <span class="inline text-[1em] leading-7">uraemia</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_67abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Symptoms of kidney failure include the following:<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_27qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_37qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_47qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_57qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup></span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">High levels of <span class="inline text-[1em] leading-7">urea</span> in the blood, which can result in:
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]"><span class="inline text-[1em] leading-7">Vomiting</span> or <span class="inline text-[1em] leading-7">diarrhea</span> (or both) that may lead to <span class="inline text-[1em] leading-7">dehydration</span></li>
<li class="text-[1em]"><span class="inline text-[1em] leading-7">Nausea</span></li>
<li class="text-[1em]">Weight loss</li>
<li class="text-[1em]">Nocturnal urination (<span class="inline text-[1em] leading-7">nocturia</span>)</li>
<li class="text-[1em]">More frequent urination, or in greater amounts than usual, with pale urine</li>
<li class="text-[1em]">Less frequent urination, or in smaller amounts than usual, with dark coloured urine</li>
<li class="text-[1em]"><span class="inline text-[1em] leading-7">Blood in the urine</span></li>
<li class="text-[1em]">Pressure, or difficulty urinating</li>
<li class="text-[1em]">Unusual amounts of urination, usually in large quantities</li>
</ul>
</li>
<li class="text-[1em]">A buildup of <span class="inline text-[1em] leading-7">phosphates</span> in the blood that diseased kidneys cannot filter out may cause:
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Itching</li>
<li class="text-[1em]">Bone damage</li>
<li class="text-[1em]"><span class="inline text-[1em] leading-7">Nonunion</span> in broken bones</li>
<li class="text-[1em]"><span class="inline text-[1em] leading-7">Muscle cramps</span> (caused by low levels of calcium which can be associated with <span class="inline text-[1em] leading-7">hyperphosphatemia</span>)</li>
</ul>
</li>
<li class="text-[1em]">A buildup of <span class="inline text-[1em] leading-7">potassium</span> in the blood that diseased kidneys cannot filter out (called <span class="inline text-[1em] leading-7">hyperkalemia</span>) may cause:
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Abnormal heart rhythms</li>
<li class="text-[1em]">Muscle paralysis<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2j68abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></li>
</ul>
</li>
<li class="text-[1em]">Failure of kidneys to remove excess fluid may cause:
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Swelling of the hands, legs, ankles, feet, or face</li>
<li class="text-[1em]">Shortness of breath due to extra fluid on the lungs (may also be caused by anemia)</li>
</ul>
</li>
<li class="text-[1em]">Healthy kidneys produce the hormone <span class="inline text-[1em] leading-7">erythropoietin</span> that stimulates the <span class="inline text-[1em] leading-7">bone marrow</span> to <span class="inline text-[1em] leading-7">make oxygen-carrying red blood cells</span>. As the kidneys fail, they produce less erythropoietin, resulting in decreased production of red blood cells to replace the natural breakdown of old red blood cells. As a result, the blood carries less <span class="inline text-[1em] leading-7">hemoglobin</span>, a condition known as <span class="inline text-[1em] leading-7">anemia</span>. This can result in:
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Feeling tired or weak</li>
<li class="text-[1em]">Memory problems</li>
<li class="text-[1em]">Difficulty concentrating</li>
<li class="text-[1em]"><span class="inline text-[1em] leading-7">Dizziness</span></li>
<li class="text-[1em]">Low blood pressure</li>
</ul>
</li>
<li class="text-[1em]">Normally proteins are too large to pass through the kidneys. However they are able to pass through when the glomeruli are damaged. This does not cause symptoms until extensive kidney damage has occurred,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1c8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup> after which symptoms include:
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Foamy or bubbly urine</li>
<li class="text-[1em]">Swelling in the hands, feet, abdomen, and face</li>
</ul>
</li>
<li class="text-[1em]">Other symptoms include:
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Appetite loss, which may include a bad taste in the mouth</li>
<li class="text-[1em]"><span class="inline text-[1em] leading-7">Difficulty sleeping</span></li>
<li class="text-[1em]">Darkening of the skin</li>
<li class="text-[1em]">With high doses of <span class="inline text-[1em] leading-7">penicillin</span>, people with kidney failure may experience <span class="inline text-[1em] leading-7">seizures</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5he8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup></li>
</ul>
</li>
</ul>
<h1 id="causes-of-kidney-failure" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Causes of Kidney Failure<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h2 id="acute-kidney-injury" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Acute kidney injury<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Acute kidney injury (previously known as acute renal failure) â€“ or AKI â€“ usually occurs when the blood supply to the kidneys is suddenly interrupted (prerenal causes, such as from accidents, injuries, or complications from surgeries like heart-bypass where kidneys are deprived of normal blood flow), when the kidneys become overloaded with toxins or suffer direct damage (intrinsic causes, such as from drug overdoses, antibiotics, chemotherapy, or bee stings<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_29qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup>), or from obstruction of urine flow (postrenal causes, such as kidney stones, enlarged prostate, or tumors). Unlike chronic kidney disease, however, the kidneys can often recover from acute kidney injury, allowing the person with AKI to resume a normal life. People with acute kidney injury require supportive treatment until their kidneys recover function, and they often remain at increased risk of developing future kidney failure.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Among the accidental causes of renal failure is the <span class="inline text-[1em] leading-7">crush syndrome</span>, when large amounts of <span class="inline text-[1em] leading-7">toxins</span> are suddenly released in the <span class="inline text-[1em] leading-7">blood circulation</span> after a long compressed <span class="inline text-[1em] leading-7">limb</span> is suddenly relieved from the pressure obstructing the blood flow through its tissues, causing <span class="inline text-[1em] leading-7">ischemia</span>. The resulting overload can lead to the clogging and the destruction of the kidneys. It is a <span class="inline text-[1em] leading-7">reperfusion injury</span> that appears after the release of the crushing pressure. The mechanism is believed to be the release into the bloodstream of muscle breakdown products â€“ notably <span class="inline text-[1em] leading-7">myoglobin</span>, <span class="inline text-[1em] leading-7">potassium</span>, and <span class="inline text-[1em] leading-7">phosphorus</span> â€“ that are the products of <span class="inline text-[1em] leading-7">rhabdomyolysis</span> (the breakdown of skeletal muscle damaged by <span class="inline text-[1em] leading-7">ischemic</span> conditions). The specific action on the <span class="inline text-[1em] leading-7">kidneys</span> is not fully understood, but may be due in part to <span class="inline text-[1em] leading-7">nephrotoxic</span> <span class="inline text-[1em] leading-7">metabolites</span> of myoglobin.</span>
<h2 id="chronic-kidney-failure-1" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Chronic kidney failure<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Chronic kidney failure has numerous causes. The most common causes of chronic failure are <span class="inline text-[1em] leading-7">diabetes mellitus</span> and long-term, uncontrolled <span class="inline text-[1em] leading-7">hypertension</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> <span class="inline text-[1em] leading-7">Polycystic kidney disease</span> is another well-known cause of chronic failure. The majority of people affected with polycystic kidney disease have a family history of the disease. Systemic lupus erythematosus (SLE) is also a known cause of chronic kidney failure. Other genetic illnesses cause kidney failure, as well. Glomerulonephritis and nephrotic syndrome are additional important causes.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Overuse of common drugs such as <span class="inline text-[1em] leading-7">ibuprofen</span>, and <span class="inline text-[1em] leading-7">acetaminophen</span> (paracetamol) can also cause chronic kidney failure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Some infectious disease agents, such as <span class="inline text-[1em] leading-7">hantavirus</span>, can attack the kidneys, causing kidney failure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></span>
<h2 id="genetic-predisposition" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Genetic predisposition<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The <em><span class="inline text-[1em] leading-7">APOL1</span></em> gene has been proposed as a major genetic risk locus for a spectrum of nondiabetic renal failure in individuals of African origin, these include <span class="inline text-[1em] leading-7">HIV-associated nephropathy</span> (HIVAN), primary nonmonogenic forms of <span class="inline text-[1em] leading-7">focal segmental glomerulosclerosis</span>, and hypertension affiliated <span class="inline text-[1em] leading-7">chronic kidney disease</span> not attributed to other etiologies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_adabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup> Two western African variants in APOL1 have been shown to be associated with end stage kidney disease in African Americans and Hispanic Americans.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ddabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup></span>
<h1 id="diagnostic-approach" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Diagnostic approach<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h2 id="measurement-for-ckd" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Measurement for CKD<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="stages-of-chronic-kidney-disease" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Stages of chronic kidney disease<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Chronic kidney disease (CKD) is classified into five stages, calculated using the glomerular filtration rate (GFR).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> The stages are defined as follows:</span>



































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Stage</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">GFR (mL/min/1.73 mÂ²)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Description</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">â‰¥90</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Kidney damage with normal or high GFR; few overt symptoms.</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">60â€“89</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Mildly reduced GFR; increasing supportive care may be needed.</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">3</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">30â€“59</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Moderately to severely reduced GFR (subdivided into 3a: 45â€“59 and 3b: 30â€“44); requires supportive care to slow progression.</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">4</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">15â€“29</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Severely reduced GFR; preparation for renal replacement therapy.</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">5</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">&lt;15</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Kidney failure (ESRD); requires dialysis or kidney transplant when feasible.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bmfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">Stage 5 CKD is considered a severe illness and requires some form of renal replacement therapy (dialysis) or kidney transplant whenever feasible.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup></span>
<h3 id="glomerular-filtration-rate" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Glomerular filtration rate<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">A normal GFR varies according to many factors, including sex, age, body size and ethnic background. Renal professionals consider the glomerular filtration rate (GFR) to be the best overall index of kidney function.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup> The National Kidney Foundation offers an easy-to-use online GFR calculator for anyone interested in knowing their glomerular filtration rate. (A serum creatinine level, a simple blood test, is needed to use the calculator.)<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup></span>
<h2 id="complications" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Complications<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Patients with end-stage renal disease undergoing hemodialysis have an increased risk of spontaneous intra-abdominal bleeding and non-occlusive mesenteric ischemia compared to the general population. In a retrospective study of hemodialysis patients presenting with acute abdominal conditions who underwent CT imaging, spontaneous intra-abdominal bleeding accounted for 21.2% of cases, and non-occlusive mesenteric ischemia for 18.1%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup> Patients undergoing peritoneal dialysis have a higher risk of peritonitis (approximately 0.3â€“0.5 episodes per patient-year) and gastrointestinal perforation compared to those on hemodialysis or the general population.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup> However, the rate of acute pancreatitis does not differ significantly from the general population.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Other major complications of kidney failure include cardiovascular disease (the leading cause of death, responsible for about 40â€“50% of mortality in end-stage renal disease as of 2023), anemia, mineral and bone disorders, infections, and neurological issues such as uremic encephalopathy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup></span>
<h2 id="treatment" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Treatment<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The treatment of acute kidney failure depends on the cause.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> The treatment of chronic kidney failure may include renal replacement therapy: hemodialysis, peritoneal dialysis, or kidney transplant.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<h3 id="diet" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Diet<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In non-dialysis CKD patients, including non-diabetics and those with type 1 or type 2 diabetes, a low-protein diet (0.6â€“0.8 g/kg/day) is recommended to slow the progression of chronic kidney disease.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A whole food, plant-based diet may help some people with kidney disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup> High-protein diets (&gt;1.3 g/kg/day), particularly those high in animal protein, may have negative effects on kidney function in CKD patients.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></span>
<h3 id="slowing-progression" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Slowing progression<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">People who receive earlier referrals to a nephrology specialist, meaning a longer time before they must start dialysis, have a shorter initial hospitalization and reduced risk of death after the start of dialysis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup> Key pharmacological interventions include renin-angiotensin system inhibitors (e.g., ACE inhibitors or ARBs) for patients with albuminuria, and SGLT2 inhibitors for CKD patients with or without diabetes and eGFR â‰¥20 ml/min/1.73 mÂ² to reduce progression risk. Blood pressure should be targeted to &lt;130/80 mmHg using these agents and lifestyle measures when tolerated.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Adults with CKD are recommended to undertake moderate-intensity physical activity for a cumulative duration of at least 150 minutes per week. Other methods of reducing disease progression include minimizing exposure to nephrotoxins such as NSAIDs and intravenous contrast.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.niddk.nih.gov/health-information/Kidney-disease/kidney-failure" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Kidney Failure&quot;</a>. <em>National Institute of Diabetes and Digestive and Kidney Diseases</em>. Retrieved 11 November 2017.</span></div></li><li id="6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20170618054600/http://www.hopkinsmedicine.org/healthlibrary/conditions/kidney_and_urinary_system_disorders/end_stage_renal_disease_esrd_85,P01474/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;What is renal failure?&quot;</a>. <em>Johns Hopkins Medicine</em>. Archived from <a href="https://www.hopkinsmedicine.org/healthlibrary/conditions/kidney_and_urinary_system_disorders/end_stage_renal_disease_esrd_85,P01474" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 18 June 2017. Retrieved 18 December 2017.</span></div></li><li id="3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Blakeley S (2010). <a href="https://books.google.com/books?id=G1-9oN0I4lAC&amp;pg=PA19" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Renal Failure and Replacement Therapies</em></a>. Springer Science &amp; Business Media. p. 19. <span class="inline text-[1em] leading-7">ISBN</span> 9781846289378.</span></div></li><li id="4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC (2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420350" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Insulin resistance in patients with chronic kidney disease&quot;</a>. <em>Journal of Biomedicine &amp; Biotechnology</em>. <strong>2012</strong> : 691369. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1155%2F2012%2F691369" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1155/2012/691369</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420350" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3420350</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22919275" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22919275</a>.</span></div></li><li id="5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://medlineplus.gov/kidneyfailure.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Kidney Failure&quot;</a>. <em>MedlinePlus</em>. Retrieved 11 November 2017.</span></div></li><li id="1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cheung AK (2005). <a href="https://books.google.com/books?id=BUE9-mY4FkoC&amp;pg=PA457" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Primer on Kidney Diseases</em></a>. Elsevier Health Sciences. p. 457. <span class="inline text-[1em] leading-7">ISBN</span> 1416023127.</span></div></li><li id="7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Clatworthy M (2010). <a href="https://books.google.com/books?id=55VOagYjaVkC&amp;pg=PA28" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Nephrology: Clinical Cases Uncovered</em></a>. John Wiley &amp; Sons. p. 28. <span class="inline text-[1em] leading-7">ISBN</span> 9781405189903.</span></div></li><li id="9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Mehrotra R, Cukor D, Unruh M, Rue T, Heagerty P, Cohen SD, et al. (March 2019). &quot;Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial&quot;. <em>Annals of Internal Medicine</em>. <strong>170</strong> (6): 369â€“379. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.7326%2FM18-2229" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.7326/M18-2229</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30802897" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30802897</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:67876948" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">67876948</a>.</span></div></li><li id="8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ferri FF (2017). <a href="https://books.google.com/books?id=wGclDwAAQBAJ&amp;pg=PA37" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Ferri&#x27;s Clinical Advisor 2018 E-Book: 5 Books in 1</em></a>. Elsevier Health Sciences. p. 37. <span class="inline text-[1em] leading-7">ISBN</span> 9780323529570.</span></div></li><li id="https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease</a></span></div></li><li id="11" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Turin TC, Tonelli M, Manns BJ, Ahmed SB, Ravani P, James MT, Hemmelgarn BR (September 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431421" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Lifetime risk of ESRD&quot;</a>. <em>J Am Soc Nephrol</em>. <strong>23</strong> (9): 1569â€“1578. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1681%2FASN.2012020164" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1681/ASN.2012020164</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431421" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3431421</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22904351" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22904351</a>.</span></div></li><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">niddk.nih.gov, <a href="https://www.niddk.nih.gov/health-information/kidney-disease/anemia" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Anemia in Chronic Kidney Disease</a></span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Moore EM, Bellomo R, Nichol AD (November 2012). <a href="https://doi.org/10.1177%2F0310057X1204000604" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The meaning of acute kidney injury and its relevance to intensive care and anaesthesia&quot;</a>. <em>Anaesthesia and Intensive Care</em>. <strong>40</strong> (6): 929â€“48. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1177%2F0310057X1204000604" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1177/0310057X1204000604</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23194202" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23194202</a>.</span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ricci Z, Ronco C (2012). <a href="https://doi.org/10.4414%2Fsmw.2012.13662" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;New insights in acute kidney failure in the critically ill&quot;</a>. <em><span class="inline text-[1em] leading-7">Swiss Medical Weekly</span></em>. <strong>142</strong> : w13662. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.4414%2Fsmw.2012.13662" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.4414/smw.2012.13662</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22923149" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22923149</a>.</span></div></li><li id="15" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20140117220151/https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001530/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Acute kidney failure&quot;</a>. <em>A.D.A.M. Medical Encyclopedia</em>. U.S. National Library of Medicine. 2012. Archived from <a href="https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001530/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 17 January 2014. Retrieved 1 January 2013.</span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Klahr S, Miller SB (March 1998). &quot;Acute oliguria&quot;. <em>The New England Journal of Medicine</em>. <strong>338</strong> (10): 671â€“5. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJM199803053381007" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJM199803053381007</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9486997" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9486997</a>.</span></div></li><li id="17" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Predictors of acute kidney injury after paraquat intoxication, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5584253/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">National Library of Medicine - National Institutes of Health</a></span></div></li><li id="18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.medlineplus.gov/ency/article/000471.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Chronic kidney disease&quot;</a>. <em>A.D.A.M. Medical Encyclopedia</em>. Medline Plus, National Institutes of Health. 2011. Retrieved 1 January 2013.</span></div></li><li id="19" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.kidneyfund.org/all-about-kidneys/stages-kidney-disease" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Stages of kidney disease&quot;</a>. <em><a href="http://www.kidneyfund.org" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">www.kidneyfund.org</a></em>. 2021-11-22. Retrieved 2023-03-09.</span></div></li><li id="20" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Grinsted P (2005-03-02). <a href="https://web.archive.org/web/20151015111748/http://www.netdoctor.co.uk/diseases/facts/kidneyfailure.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Kidney failure (renal failure with uremia, or azotaemia)&quot;</a>. <em>Netdoctor</em>. Archived from <a href="http://www.netdoctor.co.uk/diseases/facts/kidneyfailure.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 2015-10-15. Retrieved 2009-05-26.</span></div></li><li id="21" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Stein A (2007-07-01). <a href="https://web.archive.org/web/20190130063734/http://www.renalinfo.com/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Understanding Treatment Options For Renal Therapy</em></a>. Deerfield, Illinois: Baxter International Inc. p. 6. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-85959-070-6. Archived from <a href="http://www.renalinfo.com/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 2019-01-30. Retrieved 2010-07-12.</span></div></li><li id="22" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20100625040151/http://www.renalinfo.com/uk/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>The PD Companion</em></a>. Deerfield, Illinois: Baxter International Inc. 2008-05-01. pp. 14â€“15. 08/1046R. Archived from <a href="http://www.renalinfo.com/uk" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 2010-06-25. Retrieved 2010-07-12.</span></div></li><li id="23" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Amgen Inc.</span> (2009). <a href="https://www.lifeoptions.org/kidneyinfo/ckdinfo.php?page=4" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;10 Symptoms of Kidney Disease&quot;</a>. Retrieved 2009-05-26.</span></div></li><li id="24" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.medicinenet.com/hyperkalemia/page4.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Hyperkalemia&quot;</a>. <em>MedicineNet, Inc</em>. 2008-07-03. Retrieved 2009-05-26.</span></div></li><li id="25" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hebert LA, Charleston J, Miller E (2009). <a href="https://web.archive.org/web/20110505073832/http://kidney.niddk.nih.gov/kudiseases/pubs/proteinuria/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Proteinuria&quot;</a>. Archived from <a href="http://kidney.niddk.nih.gov/kudiseases/pubs/proteinuria/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 2011-05-05. Retrieved 2011-03-24.</span></div></li><li id="26" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Katzung BG (2007). <em>Basic and Clinical Pharmacology</em> (10th ed.). New York, NY: McGraw Hill Medical. p. 733. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-07-145153-6.</span></div></li><li id="27" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Silva GB, Vasconcelos AG, Rocha AM, Vasconcelos VR, Barros J, Fujishima JS, et al. (June 2017). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459532" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Acute kidney injury complicating bee stings - a review&quot;</a>. <em>Revista do Instituto de Medicina Tropical de Sao Paulo</em>. <strong>59</strong> : e25. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1590%2FS1678-9946201759025" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1590/S1678-9946201759025</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459532" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5459532</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/28591253" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28591253</a>.</span></div></li><li id="29" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kes P, BasiÄ‡-JukiÄ‡ N, LjutiÄ‡ D, Brunetta-GavraniÄ‡ B (October 2011). <a href="https://web.archive.org/web/20130719135947/http://www.amzh.hr/amc/pdf/amc_2011%20vol%2065%20supplement%203.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;[The role of arterial hypertension in development of chronic renal failure]&quot;</a> [The role of arterial hypertension in the development of chronic renal failure] (PDF). <em>Acta Medica Croatica</em> (in Croatian). <strong>65</strong> (Suppl 3): 78â€“84. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23120821" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23120821</a>. Archived from <a href="http://www.amzh.hr/amc/pdf/amc_2011%20vol%2065%20supplement%203.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> (PDF) on 2013-07-19.</span></div></li><li id="30" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Perneger TV, Whelton PK, Klag MJ (December 1994). <a href="https://doi.org/10.1056%2FNEJM199412223312502" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs&quot;</a>. <em>The New England Journal of Medicine</em>. <strong>331</strong> (25): 1675â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJM199412223312502" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJM199412223312502</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/7969358" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7969358</a>.</span></div></li><li id="31" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Appel GB, Mustonen J (2012). <a href="https://www.uptodate.com/contents/renal-involvement-with-hantavirus-infection-hemorrhagic-fever-with-renal-syndrome" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Renal involvement with hantavirus infection (hemorrhagic fever with renal syndrome)&quot;</a>. <span class="inline text-[1em] leading-7">UpToDate</span>. Retrieved 1 January 2013.</span></div></li><li id="33" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. (August 2010). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980843" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Association of trypanolytic ApoL1 variants with kidney disease in African Americans&quot;</a>. <em>Science</em>. <strong>329</strong> (5993): 841â€“5. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2010Sci...329..841G" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2010Sci...329..841G</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.1193032" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.1193032</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980843" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2980843</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20647424" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20647424</a>.</span></div></li><li id="34" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, et al. (September 2010). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921485" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene&quot;</a>. <em>Human Genetics</em>. <strong>128</strong> (3): 345â€“50. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs00439-010-0861-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s00439-010-0861-0</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921485" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2921485</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20635188" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20635188</a>.</span></div></li><li id="35" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kidney Transplantation as Primary Therapy for End-Stage Renal Disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQIâ„¢) Conference](<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2390948/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2390948/</a>)</span></div></li><li id="36" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Fadem, Stephen Z., M.D., <a href="http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">FACP, FASN. Calculators for HealthCare Professionals. National Kidney Foundation. 13 Oct 2008</a> <a href="https://web.archive.org/web/20140727183526/http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> 27 July 2014 at the <span class="inline text-[1em] leading-7">Wayback Machine</span></span></div></li><li id="37" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20140727183526/http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;GFR calculator&quot;</a>. Kidney.org. Archived from <a href="http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 2014-07-27. Retrieved 2011-09-25.</span></div></li><li id="38" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tonolini M, Ierardi AM, Carrafiello G (December 2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656237" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Letter to the editor: spontaneous renal haemorrhage in end-stage renal disease&quot;</a>. <em>Insights into Imaging</em>. <strong>6</strong> (6): 693â€“695. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs13244-015-0439-4" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s13244-015-0439-4</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656237" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4656237</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26472545" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26472545</a>.</span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000905/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000905/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000905/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623158/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623158/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623158/</a></span></div></li><li id="https://www.mdpi.com/2072-6643/16/11/1687" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mdpi.com/2072-6643/16/11/1687" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mdpi.com/2072-6643/16/11/1687</a></span></div></li><li id="40" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Chauveau P, Combe C, Fouque D, Aparicio M (November 2013). &quot;Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases&quot;. <em>Journal of Renal Nutrition</em>. <strong>23</strong> (6): 399â€“405. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1053%2Fj.jrn.2013.08.004" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1053/j.jrn.2013.08.004</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/24070587" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24070587</a>.</span></div></li><li id="https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf</a></span></div></li><li id="42" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Smart NA, Dieberg G, Ladhani M, Titus T (June 2014). &quot;Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease&quot;. <em>The Cochrane Database of Systematic Reviews</em> (6): CD007333. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F14651858.CD007333.pub2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/14651858.CD007333.pub2</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/24938824" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24938824</a>.</span></div></li><li id="43" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dirkx TC, Woodell T, Watnick S (2017). Papadakis MA, McPhee SJ, Rabow MW (eds.). <a href="http://accessmedicine.mhmedical.com/content.aspx?aid=1145435499" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Current Medical Diagnosis &amp; Treatment 2018</em></a>. New York, NY: McGraw-Hill Education.</span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Kidney_failure" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll" id="_R_" async=""></script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\"}]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Kidney_failure\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Kidney_failure\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Kidney_failure\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T4516,"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"# Kidney failure\n\n**Kidney failure**, also known as **renal failure** or **end-stage renal disease** (**ESRD**), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels.[2] Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible.[6] Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion.[2] Complications of acute and chronic failure include uremia, hyperkalemia, and volume overload.[3] Complications of chronic failure also include heart disease, high blood pressure, and anemia.[4][5]\n\nCauses of acute kidney failure include low blood pressure, blockage of the urinary tract, certain medications, muscle breakdown, and hemolytic uremic syndrome.[6] Causes of chronic kidney failure include diabetes, high blood pressure, nephrotic syndrome, and polycystic kidney disease.[6] Diagnosis of acute failure is often based on a combination of factors such as decreased urine production or increased serum creatinine.[3] Diagnosis of chronic failure follows guidelines such as KDIGO 2024, based on a glomerular filtration rate (GFR) of less than 15 mL/min/1.73 mÂ² or the need for renal replacement therapy.[1] It is also equivalent to stage 5 chronic kidney disease.[1]\n\nTreatment of acute failure depends on the underlying cause.[7] Treatment of chronic failure may include hemodialysis, peritoneal dialysis, or a kidney transplant.[2] Hemodialysis uses a machine to filter the blood outside the body.[2] In peritoneal dialysis specific fluid is placed into the abdominal cavity and then drained, with this process being repeated multiple times per day.[2] Kidney transplantation involves surgically placing a kidney from someone else and then taking immunosuppressant medication to prevent rejection.[2] Other recommended measures for chronic disease include staying active and specific dietary changes.[2] Depression is also common among patients with kidney failure, and is associated with poor outcomes including higher risk of kidney function decline, hospitalization, and death. A 2019 PCORI-funded study of patients with kidney failure receiving outpatient hemodialysis found similar effectiveness between nonpharmacological and pharmacological treatments for depression.[9]\n\nIn the United States, acute failure affects about 3 per 1,000 people a year.[8] Chronic failure affects about 2 in 1,000 people, with approximately 4 per 10,000 people newly developing the condition each year (as of 2022).[](https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease) In Canada, the lifetime risk of kidney failure or end-stage renal disease (ESRD) was estimated to be 2.66% for men and 1.76% for women.[11] Acute failure is often reversible while chronic failure often is not.[6] With appropriate treatment many with chronic disease can continue working.[2]\n# Classification\n\nKidney failure can be divided into two categories: [acute kidney failure](Acute_kidney_failure \"Acute kidney failure\") or [chronic kidney failure](Chronic_kidney_failure \"Chronic kidney failure\"). The type of renal failure is differentiated by the trend in the serum [creatinine](Creatinine#Diagnostic_use \"Creatinine\"); other factors that may help differentiate acute kidney failure from chronic kidney failure include [anemia](Anemia \"Anemia\") and the kidney size on [sonography](Sonography \"Sonography\") as chronic kidney disease generally leads to anemia and small kidney size.[12]\n\n### Acute kidney failure\n\n[Acute kidney injury](Acute_kidney_injury \"Acute kidney injury\") (AKI), previously called acute renal failure (ARF),[13][14] is a rapidly progressive loss of [renal function](Renal_function \"Renal function\"),[15] generally characterized by [oliguria](Oliguria \"Oliguria\") (decreased [urine](Urine \"Urine\") production, quantified as less than 400 [mL](Millilitres \"Millilitres\") per day in adults,[16] less than 0.5 mL/kg/h in children or less than 1 mL/kg/h in infants); and [fluid and electrolyte imbalance](Water-electrolyte_imbalance \"Water-electrolyte imbalance\"). AKI can result from a variety of causes, generally classified as _prerenal_ , _intrinsic_ , and _postrenal_. Many people diagnosed with [paraquat intoxication](Paraquat \"Paraquat\") experience AKI, sometimes requiring [hemodialysis](Hemodialysis \"Hemodialysis\").[17] The underlying cause must be identified and treated to arrest the progress, and [dialysis](Kidney_dialysis \"Kidney dialysis\") may be necessary to bridge the time gap required for treating these fundamental causes. \n\n### Chronic kidney failure\n\n[Chronic kidney disease](Chronic_kidney_disease \"Chronic kidney disease\") (CKD) can also develop slowly and, initially, show few symptoms.[18] CKD can be the long term consequence of irreversible acute disease or part of a disease progression. CKD is divided into five stages (1â€“5) based on the estimated glomerular filtration rate (eGFR). Stage 1 is defined by eGFR â‰¥90 mL/min/1.73 mÂ² with evidence of kidney damage. Stage 5 (also known as end-stage renal disease) is defined by eGFR \u003c15 mL/min/1.73 mÂ² or the need for renal replacement therapy.[19]\n\n### Acute-on-chronic kidney failure\n\nAcute kidney injuries can be present on top of chronic kidney disease, a condition called acute-on-chronic kidney failure (AoCRF). The acute part of AoCRF may be reversible, and the goal of treatment, as with AKI, is to return the person to baseline kidney function, typically measured by serum [creatinine](Creatinine \"Creatinine\"). Like AKI, AoCRF can be difficult to distinguish from chronic kidney disease if the person has not been monitored by a [physician](Physician \"Physician\") and no baseline (i.e., past) blood work is available for comparison.\n## Signs and symptoms\n\nSymptoms can vary from person to person. Someone in early stage kidney disease may not feel sick or notice symptoms as they occur. When the kidneys fail to filter properly, waste accumulates in the blood and the body, a condition called [azotemia](Azotemia \"Azotemia\"). Very low levels of azotemia may produce few, if any, symptoms. If the disease progresses, symptoms become noticeable (if the failure is of sufficient degree to cause symptoms). Kidney failure accompanied by noticeable symptoms is termed [uraemia](Uraemia \"Uraemia\").[20]\n\nSymptoms of kidney failure include the following:[20][21][22][23]\n\n* High levels of [urea](Urea \"Urea\") in the blood, which can result in: \n  * [Vomiting](Vomiting \"Vomiting\") or [diarrhea](Diarrhea \"Diarrhea\") (or both) that may lead to [dehydration](Dehydration \"Dehydration\")\n  * [Nausea](Nausea \"Nausea\")\n  * Weight loss\n  * Nocturnal urination ([nocturia](Nocturia \"Nocturia\"))\n  * More frequent urination, or in greater amounts than usual, with pale urine\n  * Less frequent urination, or in smaller amounts than usual, with dark coloured urine\n  * [Blood in the urine](Blood_in_the_urine \"Blood in the urine\")\n  * Pressure, or difficulty urinating\n  * Unusual amounts of urination, usually in large quantities\n* A buildup of [phosphates](Phosphates \"Phosphates\") in the blood that diseased kidneys cannot filter out may cause: \n  * Itching\n  * Bone damage\n  * [Nonunion](Nonunion \"Nonunion\") in broken bones\n  * [Muscle cramps](Muscle_cramps \"Muscle cramps\") (caused by low levels of calcium which can be associated with [hyperphosphatemia](Hyperphosphatemia \"Hyperphosphatemia\"))\n* A buildup of [potassium](Potassium \"Potassium\") in the blood that diseased kidneys cannot filter out (called [hyperkalemia](Hyperkalemia \"Hyperkalemia\")) may cause: \n  * Abnormal heart rhythms\n  * Muscle paralysis[24]\n* Failure of kidneys to remove excess fluid may cause: \n  * Swelling of the hands, legs, ankles, feet, or face\n  * Shortness of breath due to extra fluid on the lungs (may also be caused by anemia)\n* Healthy kidneys produce the hormone [erythropoietin](Erythropoietin \"Erythropoietin\") that stimulates the [bone marrow](Bone_marrow \"Bone marrow\") to [make oxygen-carrying red blood cells](Haematopoiesis \"Haematopoiesis\"). As the kidneys fail, they produce less erythropoietin, resulting in decreased production of red blood cells to replace the natural breakdown of old red blood cells. As a result, the blood carries less [hemoglobin](Hemoglobin \"Hemoglobin\"), a condition known as [anemia](Anemia \"Anemia\"). This can result in: \n  * Feeling tired or weak\n  * Memory problems\n  * Difficulty concentrating\n  * [Dizziness](Dizziness \"Dizziness\")\n  * Low blood pressure\n* Normally proteins are too large to pass through the kidneys. However they are able to pass through when the glomeruli are damaged. This does not cause symptoms until extensive kidney damage has occurred,[25] after which symptoms include: \n  * Foamy or bubbly urine\n  * Swelling in the hands, feet, abdomen, and face\n* Other symptoms include: \n  * Appetite loss, which may include a bad taste in the mouth\n  * [Difficulty sleeping](Insomnia \"Insomnia\")\n  * Darkening of the skin\n  * With high doses of [penicillin](Penicillin \"Penicillin\"), people with kidney failure may experience [seizures](Seizures \"Seizures\")[26]\n# Causes of Kidney Failure\n\n## Acute kidney injury\n\nAcute kidney injury (previously known as acute renal failure) â€“ or AKI â€“ usually occurs when the blood supply to the kidneys is suddenly interrupted (prerenal causes, such as from accidents, injuries, or complications from surgeries like heart-bypass where kidneys are deprived of normal blood flow), when the kidneys become overloaded with toxins or suffer direct damage (intrinsic causes, such as from drug overdoses, antibiotics, chemotherapy, or bee stings[27]), or from obstruction of urine flow (postrenal causes, such as kidney stones, enlarged prostate, or tumors). Unlike chronic kidney disease, however, the kidneys can often recover from acute kidney injury, allowing the person with AKI to resume a normal life. People with acute kidney injury require supportive treatment until their kidneys recover function, and they often remain at increased risk of developing future kidney failure.\n\nAmong the accidental causes of renal failure is the [crush syndrome](Crush_syndrome \"Crush syndrome\"), when large amounts of [toxins](Toxin \"Toxin\") are suddenly released in the [blood circulation](Blood_circulation \"Blood circulation\") after a long compressed [limb](Limb_\\(anatomy\\) \"Limb \\(anatomy\\)\") is suddenly relieved from the pressure obstructing the blood flow through its tissues, causing [ischemia](Kidney_Ischemia \"Kidney Ischemia\"). The resulting overload can lead to the clogging and the destruction of the kidneys. It is a [reperfusion injury](Reperfusion_injury \"Reperfusion injury\") that appears after the release of the crushing pressure. The mechanism is believed to be the release into the bloodstream of muscle breakdown products â€“ notably [myoglobin](Myoglobin \"Myoglobin\"), [potassium](Potassium \"Potassium\"), and [phosphorus](Phosphorus \"Phosphorus\") â€“ that are the products of [rhabdomyolysis](Rhabdomyolysis \"Rhabdomyolysis\") (the breakdown of skeletal muscle damaged by [ischemic](Ischemia \"Ischemia\") conditions). The specific action on the [kidneys](Kidney \"Kidney\") is not fully understood, but may be due in part to [nephrotoxic](Nephrotoxicity \"Nephrotoxicity\") [metabolites](Metabolite \"Metabolite\") of myoglobin. \n\n## Chronic kidney failure\n\nChronic kidney failure has numerous causes. The most common causes of chronic failure are [diabetes mellitus](Diabetes_mellitus \"Diabetes mellitus\") and long-term, uncontrolled [hypertension](Hypertension \"Hypertension\").[29] [Polycystic kidney disease](Polycystic_kidney_disease \"Polycystic kidney disease\") is another well-known cause of chronic failure. The majority of people affected with polycystic kidney disease have a family history of the disease. Systemic lupus erythematosus (SLE) is also a known cause of chronic kidney failure. Other genetic illnesses cause kidney failure, as well. Glomerulonephritis and nephrotic syndrome are additional important causes.\n\nOveruse of common drugs such as [ibuprofen](Ibuprofen \"Ibuprofen\"), and [acetaminophen](Acetaminophen \"Acetaminophen\") (paracetamol) can also cause chronic kidney failure.[30]\n\nSome infectious disease agents, such as [hantavirus](Hantavirus \"Hantavirus\"), can attack the kidneys, causing kidney failure.[31]\n\n## Genetic predisposition\n\nThe _[APOL1](APOL1 \"APOL1\")_ gene has been proposed as a major genetic risk locus for a spectrum of nondiabetic renal failure in individuals of African origin, these include [HIV-associated nephropathy](HIV-associated_nephropathy \"HIV-associated nephropathy\") (HIVAN), primary nonmonogenic forms of [focal segmental glomerulosclerosis](Focal_segmental_glomerulosclerosis \"Focal segmental glomerulosclerosis\"), and hypertension affiliated [chronic kidney disease](Chronic_kidney_disease \"Chronic kidney disease\") not attributed to other etiologies.[33] Two western African variants in APOL1 have been shown to be associated with end stage kidney disease in African Americans and Hispanic Americans.[33][34]\n# Diagnostic approach\n\n## Measurement for CKD\n\n### Stages of chronic kidney disease\n\nChronic kidney disease (CKD) is classified into five stages, calculated using the glomerular filtration rate (GFR).[19] The stages are defined as follows:\n\n| Stage | GFR (mL/min/1.73 mÂ²) | Description |\n|-------|----------------------|-------------|\n| 1     | â‰¥90                  | Kidney damage with normal or high GFR; few overt symptoms. |\n| 2     | 60â€“89                | Mildly reduced GFR; increasing supportive care may be needed. |\n| 3     | 30â€“59                | Moderately to severely reduced GFR (subdivided into 3a: 45â€“59 and 3b: 30â€“44); requires supportive care to slow progression. |\n| 4     | 15â€“29                | Severely reduced GFR; preparation for renal replacement therapy. |\n| 5     | \u003c15                  | Kidney failure (ESRD); requires dialysis or kidney transplant when feasible.[19] |\n\nStage 5 CKD is considered a severe illness and requires some form of renal replacement therapy (dialysis) or kidney transplant whenever feasible.[35]\n\n### Glomerular filtration rate\n\nA normal GFR varies according to many factors, including sex, age, body size and ethnic background. Renal professionals consider the glomerular filtration rate (GFR) to be the best overall index of kidney function.[36] The National Kidney Foundation offers an easy-to-use online GFR calculator for anyone interested in knowing their glomerular filtration rate. (A serum creatinine level, a simple blood test, is needed to use the calculator.)[37]\n## Complications\n\nPatients with end-stage renal disease undergoing hemodialysis have an increased risk of spontaneous intra-abdominal bleeding and non-occlusive mesenteric ischemia compared to the general population. In a retrospective study of hemodialysis patients presenting with acute abdominal conditions who underwent CT imaging, spontaneous intra-abdominal bleeding accounted for 21.2% of cases, and non-occlusive mesenteric ischemia for 18.1%.[38] Patients undergoing peritoneal dialysis have a higher risk of peritonitis (approximately 0.3â€“0.5 episodes per patient-year) and gastrointestinal perforation compared to those on hemodialysis or the general population.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000905/) However, the rate of acute pancreatitis does not differ significantly from the general population.[38]\n\nOther major complications of kidney failure include cardiovascular disease (the leading cause of death, responsible for about 40â€“50% of mortality in end-stage renal disease as of 2023), anemia, mineral and bone disorders, infections, and neurological issues such as uremic encephalopathy.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623158/)\n## Treatment\n\nThe treatment of acute kidney failure depends on the cause.[7] The treatment of chronic kidney failure may include renal replacement therapy: hemodialysis, peritoneal dialysis, or kidney transplant.[2]\n\n### Diet\n\nIn non-dialysis CKD patients, including non-diabetics and those with type 1 or type 2 diabetes, a low-protein diet (0.6â€“0.8 g/kg/day) is recommended to slow the progression of chronic kidney disease.\n\n[](https://www.mdpi.com/2072-6643/16/11/1687)\n\nA whole food, plant-based diet may help some people with kidney disease.[40] High-protein diets (\u003e1.3 g/kg/day), particularly those high in animal protein, may have negative effects on kidney function in CKD patients.\n\n[](https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf)\n\n### Slowing progression\n\nPeople who receive earlier referrals to a nephrology specialist, meaning a longer time before they must start dialysis, have a shorter initial hospitalization and reduced risk of death after the start of dialysis.[42] Key pharmacological interventions include renin-angiotensin system inhibitors (e.g., ACE inhibitors or ARBs) for patients with albuminuria, and SGLT2 inhibitors for CKD patients with or without diabetes and eGFR â‰¥20 ml/min/1.73 mÂ² to reduce progression risk. Blood pressure should be targeted to \u003c130/80 mmHg using these agents and lifestyle measures when tolerated.\n\n[](https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf)\n\nAdults with CKD are recommended to undertake moderate-intensity physical activity for a cumulative duration of at least 150 minutes per week. Other methods of reducing disease progression include minimizing exposure to nephrotoxins such as NSAIDs and intravenous contrast.[43]"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761887003566,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ Cheung AK (2005). [_Primer on Kidney Diseases_](https://books.google.com/books?id=BUE9-mY4FkoC\u0026pg=PA457). Elsevier Health Sciences. p. 457\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 1416023127.\",\"description\":\"1. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ Cheung AK (2005). [_Primer on Kidney Diseases_](https://books.google.com/books?id=BUE9-mY4FkoC\u0026pg=PA457). Elsevier Health Sciences. p. 457\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 1416023127.\",\"url\":\"https://books.google.com/books?id=BUE9-mY4FkoC\u0026pg=PA457\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ _**k**_ [\\\"Kidney Failure\\\"](https://www.niddk.nih.gov/health-information/Kidney-disease/kidney-failure). _National Institute of Diabetes and Digestive and Kidney Diseases_. Retrieved 11 November 2017.\",\"description\":\"2. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ _**k**_ [\\\"Kidney Failure\\\"](https://www.niddk.nih.gov/health-information/Kidney-disease/kidney-failure). _National Institute of Diabetes and Digestive and Kidney Diseases_. Retrieved 11 November 2017.\",\"url\":\"https://www.niddk.nih.gov/health-information/Kidney-disease/kidney-failure\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ Blakeley S (2010). [_Renal Failure and Replacement Therapies_](https://books.google.com/books?id=G1-9oN0I4lAC\u0026pg=PA19). Springer Science \u0026 Business Media. p. 19\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9781846289378.\",\"description\":\"3. ^ _**a**_ _**b**_ _**c**_ _**d**_ Blakeley S (2010). [_Renal Failure and Replacement Therapies_](https://books.google.com/books?id=G1-9oN0I4lAC\u0026pg=PA19). Springer Science \u0026 Business Media. p. 19\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9781846289378.\",\"url\":\"https://books.google.com/books?id=G1-9oN0I4lAC\u0026pg=PA19\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"_**a**_ _**b**_ Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC (2012). [\\\"Insulin resistance in patients with chronic kidney disease\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420350). _Journal of Biomedicine \u0026 Biotechnology_. **2012** : 691369. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1155/2012/691369](https://doi.org/10.1155%2F2012%2F691369). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3420350](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420350). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22919275](https://pubmed.ncbi.nlm.nih.gov/22919275).\",\"description\":\"4. ^ _**a**_ _**b**_ Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC (2012). [\\\"Insulin resistance in patients with chronic kidney disease\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420350). _Journal of Biomedicine \u0026 Biotechnology_. **2012** : 691369. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1155/2012/691369](https://doi.org/10.1155%2F2012%2F691369). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3420350](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420350). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22919275](https://pubmed.ncbi.nlm.nih.gov/22919275).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420350\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"_**a**_ _**b**_ [\\\"Kidney Failure\\\"](https://medlineplus.gov/kidneyfailure.html). _MedlinePlus_. Retrieved 11 November 2017.\",\"description\":\"5. ^ _**a**_ _**b**_ [\\\"Kidney Failure\\\"](https://medlineplus.gov/kidneyfailure.html). _MedlinePlus_. Retrieved 11 November 2017.\",\"url\":\"https://medlineplus.gov/kidneyfailure.html\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ [\\\"What is renal failure?\\\"](https://web.archive.org/web/20170618054600/http://www.hopkinsmedicine.org/healthlibrary/conditions/kidney_and_urinary_system_disorders/end_stage_renal_disease_esrd_85,P01474/). _Johns Hopkins Medicine_. Archived from [the original](https://www.hopkinsmedicine.org/healthlibrary/conditions/kidney_and_urinary_system_disorders/end_stage_renal_disease_esrd_85,P01474) on 18 June 2017. Retrieved 18 December 2017.\",\"description\":\"6. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ [\\\"What is renal failure?\\\"](https://web.archive.org/web/20170618054600/http://www.hopkinsmedicine.org/healthlibrary/conditions/kidney_and_urinary_system_disorders/end_stage_renal_disease_esrd_85,P01474/). _Johns Hopkins Medicine_. Archived from [the original](https://www.hopkinsmedicine.org/healthlibrary/conditions/kidney_and_urinary_system_disorders/end_stage_renal_disease_esrd_85,P01474) on 18 June 2017. Retrieved 18 December 2017.\",\"url\":\"https://web.archive.org/web/20170618054600/http://www.hopkinsmedicine.org/healthlibrary/conditions/kidney_and_urinary_system_disorders/end_stage_renal_disease_esrd_85,P01474/\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"_**a**_ _**b**_ _**c**_ Clatworthy M (2010). [_Nephrology: Clinical Cases Uncovered_](https://books.google.com/books?id=55VOagYjaVkC\u0026pg=PA28). John Wiley \u0026 Sons. p. 28\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9781405189903.\",\"description\":\"7. ^ _**a**_ _**b**_ _**c**_ Clatworthy M (2010). [_Nephrology: Clinical Cases Uncovered_](https://books.google.com/books?id=55VOagYjaVkC\u0026pg=PA28). John Wiley \u0026 Sons. p. 28\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9781405189903.\",\"url\":\"https://books.google.com/books?id=55VOagYjaVkC\u0026pg=PA28\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"_**a**_ _**b**_ Ferri FF (2017). [_Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1_](https://books.google.com/books?id=wGclDwAAQBAJ\u0026pg=PA37). Elsevier Health Sciences. p. 37\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9780323529570.\",\"description\":\"8. ^ _**a**_ _**b**_ Ferri FF (2017). [_Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1_](https://books.google.com/books?id=wGclDwAAQBAJ\u0026pg=PA37). Elsevier Health Sciences. p. 37\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9780323529570.\",\"url\":\"https://books.google.com/books?id=wGclDwAAQBAJ\u0026pg=PA37\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"** Mehrotra R, Cukor D, Unruh M, Rue T, Heagerty P, Cohen SD, et al. (March 2019). \\\"Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial\\\". _Annals of Internal Medicine_. **170** (6): 369â€“379\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/M18-2229](https://doi.org/10.7326%2FM18-2229). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30802897](https://pubmed.ncbi.nlm.nih.gov/30802897). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [67876948](https://api.semanticscholar.org/CorpusID:67876948).\",\"description\":\"9. **^** Mehrotra R, Cukor D, Unruh M, Rue T, Heagerty P, Cohen SD, et al. (March 2019). \\\"Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial\\\". _Annals of Internal Medicine_. **170** (6): 369â€“379\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/M18-2229](https://doi.org/10.7326%2FM18-2229). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30802897](https://pubmed.ncbi.nlm.nih.gov/30802897). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [67876948](https://api.semanticscholar.org/CorpusID:67876948).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"** Ferri FF (2017). [_Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1_](https://books.google.com/books?id=wGclDwAAQBAJ\u0026pg=PA294). Elsevier Health Sciences. p. 294\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9780323529570.\",\"description\":\"10. **^** Ferri FF (2017). [_Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1_](https://books.google.com/books?id=wGclDwAAQBAJ\u0026pg=PA294). Elsevier Health Sciences. p. 294\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9780323529570.\",\"url\":\"https://books.google.com/books?id=wGclDwAAQBAJ\u0026pg=PA294\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"** Turin TC, Tonelli M, Manns BJ, Ahmed SB, Ravani P, James MT, Hemmelgarn BR (September 2012). [\\\"Lifetime risk of ESRD\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431421). _J Am Soc Nephrol_. **23** (9): 1569â€“1578\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1681/ASN.2012020164](https://doi.org/10.1681%2FASN.2012020164). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3431421](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431421). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22904351](https://pubmed.ncbi.nlm.nih.gov/22904351).\",\"description\":\"11. **^** Turin TC, Tonelli M, Manns BJ, Ahmed SB, Ravani P, James MT, Hemmelgarn BR (September 2012). [\\\"Lifetime risk of ESRD\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431421). _J Am Soc Nephrol_. **23** (9): 1569â€“1578\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1681/ASN.2012020164](https://doi.org/10.1681%2FASN.2012020164). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3431421](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431421). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22904351](https://pubmed.ncbi.nlm.nih.gov/22904351).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431421\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"** niddk.nih.gov, [Anemia in Chronic Kidney Disease](\u003chttps://www.niddk.nih.gov/health-information/kidney-disease/anemia\u003e)\",\"description\":\"12. **^** niddk.nih.gov, [Anemia in Chronic Kidney Disease](\u003chttps://www.niddk.nih.gov/health-information/kidney-disease/anemia\u003e)\",\"url\":\"\u003chttps://www.niddk.nih.gov/health-information/kidney-disease/anemia\u003e\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"** Moore EM, Bellomo R, Nichol AD (November 2012). [\\\"The meaning of acute kidney injury and its relevance to intensive care and anaesthesia\\\"](https://doi.org/10.1177%2F0310057X1204000604). _Anaesthesia and Intensive Care_. **40** (6): 929â€“48\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/0310057X1204000604](https://doi.org/10.1177%2F0310057X1204000604). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23194202](https://pubmed.ncbi.nlm.nih.gov/23194202).\",\"description\":\"13. **^** Moore EM, Bellomo R, Nichol AD (November 2012). [\\\"The meaning of acute kidney injury and its relevance to intensive care and anaesthesia\\\"](https://doi.org/10.1177%2F0310057X1204000604). _Anaesthesia and Intensive Care_. **40** (6): 929â€“48\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/0310057X1204000604](https://doi.org/10.1177%2F0310057X1204000604). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23194202](https://pubmed.ncbi.nlm.nih.gov/23194202).\",\"url\":\"https://doi.org/10.1177%2F0310057X1204000604\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"** Ricci Z, Ronco C (2012). [\\\"New insights in acute kidney failure in the critically ill\\\"](https://doi.org/10.4414%2Fsmw.2012.13662). _[Swiss Medical Weekly](Swiss_Medical_Weekly \\\"Swiss Medical Weekly\\\")_. **142** : w13662. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.4414/smw.2012.13662](https://doi.org/10.4414%2Fsmw.2012.13662). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22923149](https://pubmed.ncbi.nlm.nih.gov/22923149).\",\"description\":\"14. **^** Ricci Z, Ronco C (2012). [\\\"New insights in acute kidney failure in the critically ill\\\"](https://doi.org/10.4414%2Fsmw.2012.13662). _[Swiss Medical Weekly](Swiss_Medical_Weekly \\\"Swiss Medical Weekly\\\")_. **142** : w13662. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.4414/smw.2012.13662](https://doi.org/10.4414%2Fsmw.2012.13662). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22923149](https://pubmed.ncbi.nlm.nih.gov/22923149).\",\"url\":\"https://doi.org/10.4414%2Fsmw.2012.13662\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"** [\\\"Acute kidney failure\\\"](https://web.archive.org/web/20140117220151/https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001530/). _A.D.A.M. Medical Encyclopedia_. U.S. National Library of Medicine. 2012. Archived from [the original](https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001530/) on 17 January 2014. Retrieved 1 January 2013.\",\"description\":\"15. **^** [\\\"Acute kidney failure\\\"](https://web.archive.org/web/20140117220151/https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001530/). _A.D.A.M. Medical Encyclopedia_. U.S. National Library of Medicine. 2012. Archived from [the original](https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001530/) on 17 January 2014. Retrieved 1 January 2013.\",\"url\":\"https://web.archive.org/web/20140117220151/https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001530/\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"** Klahr S, Miller SB (March 1998). \\\"Acute oliguria\\\". _The New England Journal of Medicine_. **338** (10): 671â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJM199803053381007](https://doi.org/10.1056%2FNEJM199803053381007). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9486997](https://pubmed.ncbi.nlm.nih.gov/9486997).\",\"description\":\"16. **^** Klahr S, Miller SB (March 1998). \\\"Acute oliguria\\\". _The New England Journal of Medicine_. **338** (10): 671â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJM199803053381007](https://doi.org/10.1056%2FNEJM199803053381007). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9486997](https://pubmed.ncbi.nlm.nih.gov/9486997).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"** Predictors of acute kidney injury after paraquat intoxication, [National Library of Medicine - National Institutes of Health](\u003chttps://pmc.ncbi.nlm.nih.gov/articles/PMC5584253/\u003e)\",\"description\":\"17. **^** Predictors of acute kidney injury after paraquat intoxication, [National Library of Medicine - National Institutes of Health](\u003chttps://pmc.ncbi.nlm.nih.gov/articles/PMC5584253/\u003e)\",\"url\":\"\u003chttps://pmc.ncbi.nlm.nih.gov/articles/PMC5584253/\u003e\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"** [\\\"Chronic kidney disease\\\"](https://www.medlineplus.gov/ency/article/000471.htm). _A.D.A.M. Medical Encyclopedia_. Medline Plus, National Institutes of Health. 2011. Retrieved 1 January 2013.\",\"description\":\"18. **^** [\\\"Chronic kidney disease\\\"](https://www.medlineplus.gov/ency/article/000471.htm). _A.D.A.M. Medical Encyclopedia_. Medline Plus, National Institutes of Health. 2011. Retrieved 1 January 2013.\",\"url\":\"https://www.medlineplus.gov/ency/article/000471.htm\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"** [\\\"Stages of kidney disease\\\"](https://www.kidneyfund.org/all-about-kidneys/stages-kidney-disease). _www.kidneyfund.org_. 2021-11-22. Retrieved 2023-03-09.\",\"description\":\"19. **^** [\\\"Stages of kidney disease\\\"](https://www.kidneyfund.org/all-about-kidneys/stages-kidney-disease). _www.kidneyfund.org_. 2021-11-22. Retrieved 2023-03-09.\",\"url\":\"https://www.kidneyfund.org/all-about-kidneys/stages-kidney-disease\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"_**a**_ _**b**_ Grinsted P (2005-03-02). [\\\"Kidney failure (renal failure with uremia, or azotaemia)\\\"](https://web.archive.org/web/20151015111748/http://www.netdoctor.co.uk/diseases/facts/kidneyfailure.htm). _Netdoctor_. Archived from [the original](http://www.netdoctor.co.uk/diseases/facts/kidneyfailure.htm) on 2015-10-15. Retrieved 2009-05-26.\",\"description\":\"20. ^ _**a**_ _**b**_ Grinsted P (2005-03-02). [\\\"Kidney failure (renal failure with uremia, or azotaemia)\\\"](https://web.archive.org/web/20151015111748/http://www.netdoctor.co.uk/diseases/facts/kidneyfailure.htm). _Netdoctor_. Archived from [the original](http://www.netdoctor.co.uk/diseases/facts/kidneyfailure.htm) on 2015-10-15. Retrieved 2009-05-26.\",\"url\":\"https://web.archive.org/web/20151015111748/http://www.netdoctor.co.uk/diseases/facts/kidneyfailure.htm\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"** Stein A (2007-07-01). [_Understanding Treatment Options For Renal Therapy_](https://web.archive.org/web/20190130063734/http://www.renalinfo.com/). Deerfield, Illinois: Baxter International Inc. p. 6\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-85959-070-6. Archived from [the original](http://www.renalinfo.com/) on 2019-01-30. Retrieved 2010-07-12.\",\"description\":\"21. **^** Stein A (2007-07-01). [_Understanding Treatment Options For Renal Therapy_](https://web.archive.org/web/20190130063734/http://www.renalinfo.com/). Deerfield, Illinois: Baxter International Inc. p. 6\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-85959-070-6. Archived from [the original](http://www.renalinfo.com/) on 2019-01-30. Retrieved 2010-07-12.\",\"url\":\"https://web.archive.org/web/20190130063734/http://www.renalinfo.com/\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"** [_The PD Companion_](https://web.archive.org/web/20100625040151/http://www.renalinfo.com/uk/). Deerfield, Illinois: Baxter International Inc. 2008-05-01. pp. 14â€“15\\\\. 08/1046R. Archived from [the original](http://www.renalinfo.com/uk) on 2010-06-25. Retrieved 2010-07-12.\",\"description\":\"22. **^** [_The PD Companion_](https://web.archive.org/web/20100625040151/http://www.renalinfo.com/uk/). Deerfield, Illinois: Baxter International Inc. 2008-05-01. pp. 14â€“15\\\\. 08/1046R. Archived from [the original](http://www.renalinfo.com/uk) on 2010-06-25. Retrieved 2010-07-12.\",\"url\":\"https://web.archive.org/web/20100625040151/http://www.renalinfo.com/uk/\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"** [Amgen Inc.](Amgen \\\"Amgen\\\") (2009). [\\\"10 Symptoms of Kidney Disease\\\"](https://www.lifeoptions.org/kidneyinfo/ckdinfo.php?page=4). Retrieved 2009-05-26.\",\"description\":\"23. **^** [Amgen Inc.](Amgen \\\"Amgen\\\") (2009). [\\\"10 Symptoms of Kidney Disease\\\"](https://www.lifeoptions.org/kidneyinfo/ckdinfo.php?page=4). Retrieved 2009-05-26.\",\"url\":\"Amgen \\\"Amgen\\\"\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"** [\\\"Hyperkalemia\\\"](https://www.medicinenet.com/hyperkalemia/page4.htm). _MedicineNet, Inc_. 2008-07-03. Retrieved 2009-05-26.\",\"description\":\"24. **^** [\\\"Hyperkalemia\\\"](https://www.medicinenet.com/hyperkalemia/page4.htm). _MedicineNet, Inc_. 2008-07-03. Retrieved 2009-05-26.\",\"url\":\"https://www.medicinenet.com/hyperkalemia/page4.htm\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"** Hebert LA, Charleston J, Miller E (2009). [\\\"Proteinuria\\\"](https://web.archive.org/web/20110505073832/http://kidney.niddk.nih.gov/kudiseases/pubs/proteinuria/). Archived from [the original](http://kidney.niddk.nih.gov/kudiseases/pubs/proteinuria/) on 2011-05-05. Retrieved 2011-03-24.\",\"description\":\"25. **^** Hebert LA, Charleston J, Miller E (2009). [\\\"Proteinuria\\\"](https://web.archive.org/web/20110505073832/http://kidney.niddk.nih.gov/kudiseases/pubs/proteinuria/). Archived from [the original](http://kidney.niddk.nih.gov/kudiseases/pubs/proteinuria/) on 2011-05-05. Retrieved 2011-03-24.\",\"url\":\"https://web.archive.org/web/20110505073832/http://kidney.niddk.nih.gov/kudiseases/pubs/proteinuria/\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"** Katzung BG (2007). _Basic and Clinical Pharmacology_ (10th ed.). New York, NY: McGraw Hill Medical. p. 733\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-07-145153-6.\",\"description\":\"26. **^** Katzung BG (2007). _Basic and Clinical Pharmacology_ (10th ed.). New York, NY: McGraw Hill Medical. p. 733\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-07-145153-6.\",\"url\":\"ISBN_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"** Silva GB, Vasconcelos AG, Rocha AM, Vasconcelos VR, Barros J, Fujishima JS, et al. (June 2017). [\\\"Acute kidney injury complicating bee stings - a review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459532). _Revista do Instituto de Medicina Tropical de Sao Paulo_. **59** : e25. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1590/S1678-9946201759025](https://doi.org/10.1590%2FS1678-9946201759025). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5459532](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459532). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28591253](https://pubmed.ncbi.nlm.nih.gov/28591253).\",\"description\":\"27. **^** Silva GB, Vasconcelos AG, Rocha AM, Vasconcelos VR, Barros J, Fujishima JS, et al. (June 2017). [\\\"Acute kidney injury complicating bee stings - a review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459532). _Revista do Instituto de Medicina Tropical de Sao Paulo_. **59** : e25. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1590/S1678-9946201759025](https://doi.org/10.1590%2FS1678-9946201759025). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5459532](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459532). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28591253](https://pubmed.ncbi.nlm.nih.gov/28591253).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459532\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"** National Kidney and Urologic Diseases Information Clearinghouse (2012). [\\\"The Kidneys and How They Work\\\"](https://web.archive.org/web/20150502081848/http://kidney.niddk.nih.gov/Kudiseases/pubs/yourkidneys/#7). National Institute of Diabetes and Digestive and Kidney Diseases. Archived from [the original](http://kidney.niddk.nih.gov/Kudiseases/pubs/yourkidneys/#7) on 2 May 2015. Retrieved 1 January 2013.\",\"description\":\"28. **^** National Kidney and Urologic Diseases Information Clearinghouse (2012). [\\\"The Kidneys and How They Work\\\"](https://web.archive.org/web/20150502081848/http://kidney.niddk.nih.gov/Kudiseases/pubs/yourkidneys/#7). National Institute of Diabetes and Digestive and Kidney Diseases. Archived from [the original](http://kidney.niddk.nih.gov/Kudiseases/pubs/yourkidneys/#7) on 2 May 2015. Retrieved 1 January 2013.\",\"url\":\"https://web.archive.org/web/20150502081848/http://kidney.niddk.nih.gov/Kudiseases/pubs/yourkidneys/#7\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"** Kes P, BasiÄ‡-JukiÄ‡ N, LjutiÄ‡ D, Brunetta-GavraniÄ‡ B (October 2011). [\\\"[The role of arterial hypertension in development of chronic renal failure]\\\"](https://web.archive.org/web/20130719135947/http://www.amzh.hr/amc/pdf/amc_2011%20vol%2065%20supplement%203.pdf) [The role of arterial hypertension in the development of chronic renal failure] (PDF). _Acta Medica Croatica_ (in Croatian). **65** (Suppl 3): 78â€“84\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23120821](https://pubmed.ncbi.nlm.nih.gov/23120821). Archived from [the original](http://www.amzh.hr/amc/pdf/amc_2011%20vol%2065%20supplement%203.pdf) (PDF) on 2013-07-19.\",\"description\":\"29. **^** Kes P, BasiÄ‡-JukiÄ‡ N, LjutiÄ‡ D, Brunetta-GavraniÄ‡ B (October 2011). [\\\"[The role of arterial hypertension in development of chronic renal failure]\\\"](https://web.archive.org/web/20130719135947/http://www.amzh.hr/amc/pdf/amc_2011%20vol%2065%20supplement%203.pdf) [The role of arterial hypertension in the development of chronic renal failure] (PDF). _Acta Medica Croatica_ (in Croatian). **65** (Suppl 3): 78â€“84\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23120821](https://pubmed.ncbi.nlm.nih.gov/23120821). Archived from [the original](http://www.amzh.hr/amc/pdf/amc_2011%20vol%2065%20supplement%203.pdf) (PDF) on 2013-07-19.\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"** Perneger TV, Whelton PK, Klag MJ (December 1994). [\\\"Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs\\\"](https://doi.org/10.1056%2FNEJM199412223312502). _The New England Journal of Medicine_. **331** (25): 1675â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJM199412223312502](https://doi.org/10.1056%2FNEJM199412223312502). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7969358](https://pubmed.ncbi.nlm.nih.gov/7969358).\",\"description\":\"30. **^** Perneger TV, Whelton PK, Klag MJ (December 1994). [\\\"Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs\\\"](https://doi.org/10.1056%2FNEJM199412223312502). _The New England Journal of Medicine_. **331** (25): 1675â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJM199412223312502](https://doi.org/10.1056%2FNEJM199412223312502). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7969358](https://pubmed.ncbi.nlm.nih.gov/7969358).\",\"url\":\"https://doi.org/10.1056%2FNEJM199412223312502\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"** Appel GB, Mustonen J (2012). [\\\"Renal involvement with hantavirus infection (hemorrhagic fever with renal syndrome)\\\"](https://www.uptodate.com/contents/renal-involvement-with-hantavirus-infection-hemorrhagic-fever-with-renal-syndrome). [UpToDate](UpToDate \\\"UpToDate\\\"). Retrieved 1 January 2013.\",\"description\":\"31. **^** Appel GB, Mustonen J (2012). [\\\"Renal involvement with hantavirus infection (hemorrhagic fever with renal syndrome)\\\"](https://www.uptodate.com/contents/renal-involvement-with-hantavirus-infection-hemorrhagic-fever-with-renal-syndrome). [UpToDate](UpToDate \\\"UpToDate\\\"). Retrieved 1 January 2013.\",\"url\":\"https://www.uptodate.com/contents/renal-involvement-with-hantavirus-infection-hemorrhagic-fever-with-renal-syndrome\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"** Bostrom MA, Freedman BI (June 2010). [\\\"The spectrum of MYH9-associated nephropathy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890964). _Clinical Journal of the American Society of Nephrology_. **5** (6): 1107â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2215/CJN.08721209](https://doi.org/10.2215%2FCJN.08721209). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4890964](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890964). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20299374](https://pubmed.ncbi.nlm.nih.gov/20299374).\",\"description\":\"32. **^** Bostrom MA, Freedman BI (June 2010). [\\\"The spectrum of MYH9-associated nephropathy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890964). _Clinical Journal of the American Society of Nephrology_. **5** (6): 1107â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2215/CJN.08721209](https://doi.org/10.2215%2FCJN.08721209). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4890964](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890964). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20299374](https://pubmed.ncbi.nlm.nih.gov/20299374).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890964\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"** Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. (August 2010). [\\\"Association of trypanolytic ApoL1 variants with kidney disease in African Americans\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980843). _Science_. **329** (5993): 841â€“5\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2010Sci...329..841G](https://ui.adsabs.harvard.edu/abs/2010Sci...329..841G). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1193032](https://doi.org/10.1126%2Fscience.1193032). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2980843](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980843). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20647424](https://pubmed.ncbi.nlm.nih.gov/20647424).\",\"description\":\"33. **^** Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. (August 2010). [\\\"Association of trypanolytic ApoL1 variants with kidney disease in African Americans\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980843). _Science_. **329** (5993): 841â€“5\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2010Sci...329..841G](https://ui.adsabs.harvard.edu/abs/2010Sci...329..841G). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1193032](https://doi.org/10.1126%2Fscience.1193032). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2980843](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980843). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20647424](https://pubmed.ncbi.nlm.nih.gov/20647424).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980843\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"** Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, et al. (September 2010). [\\\"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921485). _Human Genetics_. **128** (3): 345â€“50\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00439-010-0861-0](https://doi.org/10.1007%2Fs00439-010-0861-0). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2921485](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921485). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20635188](https://pubmed.ncbi.nlm.nih.gov/20635188).\",\"description\":\"34. **^** Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, et al. (September 2010). [\\\"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921485). _Human Genetics_. **128** (3): 345â€“50\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00439-010-0861-0](https://doi.org/10.1007%2Fs00439-010-0861-0). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2921485](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921485). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20635188](https://pubmed.ncbi.nlm.nih.gov/20635188).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921485\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"** Kidney Transplantation as Primary Therapy for End-Stage Renal Disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQIâ„¢) Conference](\u003chttps://pmc.ncbi.nlm.nih.gov/articles/PMC2390948/\u003e)\",\"description\":\"35. **^** Kidney Transplantation as Primary Therapy for End-Stage Renal Disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQIâ„¢) Conference](\u003chttps://pmc.ncbi.nlm.nih.gov/articles/PMC2390948/\u003e)\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2390948/\u003e\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"** Fadem, Stephen Z., M.D., [FACP, FASN. Calculators for HealthCare Professionals. National Kidney Foundation. 13 Oct 2008](http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm) [Archived](https://web.archive.org/web/20140727183526/http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm) 27 July 2014 at the [Wayback Machine](Wayback_Machine \\\"Wayback Machine\\\")\",\"description\":\"36. **^** Fadem, Stephen Z., M.D., [FACP, FASN. Calculators for HealthCare Professionals. National Kidney Foundation. 13 Oct 2008](http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm) [Archived](https://web.archive.org/web/20140727183526/http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm) 27 July 2014 at the [Wayback Machine](Wayback_Machine \\\"Wayback Machine\\\")\",\"url\":\"http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"** [\\\"GFR calculator\\\"](https://web.archive.org/web/20140727183526/http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm). Kidney.org. Archived from [the original](http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm) on 2014-07-27. Retrieved 2011-09-25.\",\"description\":\"37. **^** [\\\"GFR calculator\\\"](https://web.archive.org/web/20140727183526/http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm). Kidney.org. Archived from [the original](http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm) on 2014-07-27. Retrieved 2011-09-25.\",\"url\":\"https://web.archive.org/web/20140727183526/http://www.kidney.org/professionals/KDOQI/gfr_calculator.cfm\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"** Tonolini M, Ierardi AM, Carrafiello G (December 2015). [\\\"Letter to the editor: spontaneous renal haemorrhage in end-stage renal disease\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656237). _Insights into Imaging_. **6** (6): 693â€“695\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s13244-015-0439-4](https://doi.org/10.1007%2Fs13244-015-0439-4). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4656237](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656237). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26472545](https://pubmed.ncbi.nlm.nih.gov/26472545).\",\"description\":\"38. **^** Tonolini M, Ierardi AM, Carrafiello G (December 2015). [\\\"Letter to the editor: spontaneous renal haemorrhage in end-stage renal disease\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656237). _Insights into Imaging_. **6** (6): 693â€“695\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s13244-015-0439-4](https://doi.org/10.1007%2Fs13244-015-0439-4). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4656237](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656237). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26472545](https://pubmed.ncbi.nlm.nih.gov/26472545).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656237\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"** Rughooputh MS, Zeng R, Yao Y (28 December 2015). [\\\"Protein Diet Restriction Slows Chronic Kidney Disease Progression in Non-Diabetic and in Type 1 Diabetic Patients, but Not in Type 2 Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials Using Glomerular Filtration Rate as a Surrogate\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692386). _PLOS ONE_. **10** (12): e0145505. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2015PLoSO..1045505R](https://ui.adsabs.harvard.edu/abs/2015PLoSO..1045505R). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pone.0145505](https://doi.org/10.1371%2Fjournal.pone.0145505). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4692386](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692386). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26710078](https://pubmed.ncbi.nlm.nih.gov/26710078).\",\"description\":\"39. **^** Rughooputh MS, Zeng R, Yao Y (28 December 2015). [\\\"Protein Diet Restriction Slows Chronic Kidney Disease Progression in Non-Diabetic and in Type 1 Diabetic Patients, but Not in Type 2 Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials Using Glomerular Filtration Rate as a Surrogate\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692386). _PLOS ONE_. **10** (12): e0145505. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2015PLoSO..1045505R](https://ui.adsabs.harvard.edu/abs/2015PLoSO..1045505R). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pone.0145505](https://doi.org/10.1371%2Fjournal.pone.0145505). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4692386](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692386). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26710078](https://pubmed.ncbi.nlm.nih.gov/26710078).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692386\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"** Chauveau P, Combe C, Fouque D, Aparicio M (November 2013). \\\"Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases\\\". _Journal of Renal Nutrition_. **23** (6): 399â€“405\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/j.jrn.2013.08.004](https://doi.org/10.1053%2Fj.jrn.2013.08.004). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24070587](https://pubmed.ncbi.nlm.nih.gov/24070587).\",\"description\":\"40. **^** Chauveau P, Combe C, Fouque D, Aparicio M (November 2013). \\\"Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases\\\". _Journal of Renal Nutrition_. **23** (6): 399â€“405\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/j.jrn.2013.08.004](https://doi.org/10.1053%2Fj.jrn.2013.08.004). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24070587](https://pubmed.ncbi.nlm.nih.gov/24070587).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"** Bernstein AM, Treyzon L, Li Z (April 2007). \\\"Are high-protein, vegetable-based diets safe for kidney function? A review of the literature\\\". _Journal of the American Dietetic Association_. **107** (4): 644â€“50\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jada.2007.01.002](https://doi.org/10.1016%2Fj.jada.2007.01.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17383270](https://pubmed.ncbi.nlm.nih.gov/17383270). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [39551628](https://api.semanticscholar.org/CorpusID:39551628).\",\"description\":\"41. **^** Bernstein AM, Treyzon L, Li Z (April 2007). \\\"Are high-protein, vegetable-based diets safe for kidney function? A review of the literature\\\". _Journal of the American Dietetic Association_. **107** (4): 644â€“50\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jada.2007.01.002](https://doi.org/10.1016%2Fj.jada.2007.01.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17383270](https://pubmed.ncbi.nlm.nih.gov/17383270). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [39551628](https://api.semanticscholar.org/CorpusID:39551628).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"** Smart NA, Dieberg G, Ladhani M, Titus T (June 2014). \\\"Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease\\\". _The Cochrane Database of Systematic Reviews_ (6): CD007333. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD007333.pub2](https://doi.org/10.1002%2F14651858.CD007333.pub2). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24938824](https://pubmed.ncbi.nlm.nih.gov/24938824).\",\"description\":\"42. **^** Smart NA, Dieberg G, Ladhani M, Titus T (June 2014). \\\"Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease\\\". _The Cochrane Database of Systematic Reviews_ (6): CD007333. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD007333.pub2](https://doi.org/10.1002%2F14651858.CD007333.pub2). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24938824](https://pubmed.ncbi.nlm.nih.gov/24938824).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"** Dirkx TC, Woodell T, Watnick S (2017). Papadakis MA, McPhee SJ, Rabow MW (eds.). [_Current Medical Diagnosis \u0026 Treatment 2018_](http://accessmedicine.mhmedical.com/content.aspx?aid=1145435499). New York, NY: McGraw-Hill Education.\",\"description\":\"43. **^** Dirkx TC, Woodell T, Watnick S (2017). Papadakis MA, McPhee SJ, Rabow MW (eds.). [_Current Medical Diagnosis \u0026 Treatment 2018_](http://accessmedicine.mhmedical.com/content.aspx?aid=1145435499). New York, NY: McGraw-Hill Education.\",\"url\":\"http://accessmedicine.mhmedical.com/content.aspx?aid=1145435499\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Chronic failure affects about 1 in 1,000 people with 3 per 10,000 people newly developing the condition each year.[1][10]\",\"explanation\":\"These prevalence and incidence figures for chronic kidney failure in the US are outdated based on data from around 2005-2017. As of 2022, the prevalence is approximately 2.4 per 1,000 people, and the incidence is about 3.9 per 10,000 people per year, reflecting changes in population demographics, disease management, and reporting.\",\"fixedText\":\"Update the sentence to: \\\"Chronic failure affects about 2 in 1,000 people in the US, with approximately 4 per 10,000 people newly developing the condition each year (as of 2022).\\\"\",\"evidenceSource\":\"[](https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Chronic : 1 per 1,000 (US)[1]\",\"explanation\":\"Reference [1] (Cheung 2005) provides outdated prevalence data from 2005; current data as of 2022 shows approximately 2.4 per 1,000, invalidating the cited figure for a contemporary encyclopedia entry.\",\"fixedText\":\"Since the infobox table is to be removed except for the image and caption, this entry will be eliminated; update the corresponding prose statistic as noted above.\",\"evidenceSource\":\"[](https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease)\"},{\"criticality\":\"Non-Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[No specific text; overall section]\",\"explanation\":\"The section lacks mention of recent guidelines, such as the 2024 KDIGO updates on CKD classification and management, which refine diagnostic criteria and emphasize early intervention, relevant for currency up to 2025.\",\"fixedText\":\"Add a brief note in the diagnostic paragraph: \\\"Diagnosis follows guidelines such as KDIGO 2024, based on a glomerular filtration rate (GFR) of less than 15 mL/min/1.73 mÂ² or the need for renal replacement therapy.\\\"\",\"evidenceSource\":\"[](https://kdigo.org/guidelines/ckd-evaluation-and-management/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"CKD is divided into 5 different stages (1â€“5) according to the estimated glomerular filtration rate (eGFR). In CKD1 eGFR is normal and in CKD5 eGFR has decreased to less than 15 ml/min.[19]\",\"explanation\":\"The eGFR values lack complete units (standard is mL/min/1.73 mÂ², normalized to body surface area). Additionally, stage 1 CKD requires evidence of kidney damage despite normal/high eGFR (â‰¥90 mL/min/1.73 mÂ²), not just \\\"normal\\\" eGFR; without damage, it is not classified as CKD. This misstates the diagnostic criteria per KDIGO and NKF guidelines, potentially leading to incorrect classification.\",\"fixedText\":\"Revise to: \\\"CKD is divided into five stages (1â€“5) based on the estimated glomerular filtration rate (eGFR). Stage 1 is defined by eGFR â‰¥90 mL/min/1.73 mÂ² with evidence of kidney damage. Stage 5 (also known as end-stage renal disease) is defined by eGFR \u003c15 mL/min/1.73 mÂ² or the need for renal replacement therapy.[19]\\\"\",\"evidenceSource\":\"[19] https://www.kidneyfund.org/all-about-kidneys/stages-kidney-disease and KDIGO CKD guidelines\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"Polycystic kidney disease, which causes large, fluid-filled cysts on the kidneys and sometimes the liver, can cause: Pain in the back or side\",\"explanation\":\"Polycystic kidney disease (PKD) is a specific cause of chronic kidney failure, as listed in the article introduction and covered under Causes \u003e Genetic predisposition in the article structure. Back or side pain is a symptom of PKD itself, not a general symptom of kidney failure, leading to misstatement of applicability and potential duplication of content from other sections.\",\"fixedText\":\"Remove the entire paragraph on polycystic kidney disease.\",\"evidenceSource\":\"Article intro [6]; article structure; Mayo Clinic: PKD symptoms include high blood pressure, belly/back pain, but distinct from general kidney failure symptoms.\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Excess protein in the blood\",\"explanation\":\"Kidney failure typically causes proteinuria (protein loss in urine) leading to low blood protein (hypoalbuminemia), not excess protein in the blood. No cited sources ([20][21][22][23]) or authoritative references support excess blood protein as a symptom; it contradicts standard pathophysiology.\",\"fixedText\":\"Remove \\\"Excess protein in the blood\\\" from the list of other symptoms.\",\"evidenceSource\":\"Cleveland Clinic on proteinuria; Mayo Clinic CKD symptoms; National Kidney Foundation: symptoms include foamy urine from protein loss, not excess in blood.\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"The _[APOL1](APOL1 \\\"APOL1\\\")_ gene has been proposed as a major genetic risk locus for a spectrum of nondiabetic renal failure in individuals of African origin, these include [HIV-associated nephropathy](HIV-associated_nephropathy \\\"HIV-associated nephropathy\\\") (HIVAN), primary nonmonogenic forms of [focal segmental glomerulosclerosis](Focal_segmental_glomerulosclerosis \\\"Focal segmental glomerulosclerosis\\\"), and hypertension affiliated [chronic kidney disease](Chronic_kidney_disease \\\"Chronic kidney disease\\\") not attributed to other etiologies.[32]\",\"explanation\":\"Reference [32] is about MYH9-associated nephropathy and does not discuss APOL1 as the major genetic risk locus. This misattributes the source for the claim about APOL1's role in kidney disease among individuals of African origin.\",\"fixedText\":\"Replace [32] with [33], which correctly supports the association of APOL1 variants with kidney disease in African Americans.\",\"evidenceSource\":\"[33]\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"...and they often remain at increased risk of developing future kidney failure.[28]\",\"explanation\":\"Reference [28] is a general overview of kidney function and does not address recovery from acute kidney injury (AKI) or the increased risk of future kidney failure following AKI.\",\"fixedText\":\"Remove the unsupported citation [28]. The claim is accurate based on medical literature and can stand without citation or with a new one if needed.\",\"evidenceSource\":\"Chawla LS, et al. (2012). Chronic kidney disease after acute kidney injury: a systematic review. Kidney Int. 81(5):477-85. [](https://pubmed.ncbi.nlm.nih.gov/22113526/)\"},{\"criticality\":\"Missing Information\",\"issueType\":\"Missing Information\",\"problematicText\":\"[No specific text; refers to the Acute kidney injury subsection overall]\",\"explanation\":\"The subsection on acute kidney injury omits postrenal causes, such as urinary tract obstruction (e.g., kidney stones, enlarged prostate, tumors), which is a standard category of AKI alongside prerenal (reduced blood flow) and intrinsic (direct kidney damage) causes. This creates a knowledge gap in comprehensively listing AKI etiologies.\",\"fixedText\":\"Add a brief mention of postrenal causes, e.g., \\\"Postrenal AKI results from obstruction of urine flow, such as from kidney stones or prostate enlargement.\\\"\",\"evidenceSource\":\"Mayo Clinic: Acute kidney injury - Symptoms and causes. [](https://www.mayoclinic.org/diseases-conditions/kidney-failure/symptoms-causes/syc-20369048)\"},{\"criticality\":\"Missing Information\",\"issueType\":\"Missing Information\",\"problematicText\":\"[No specific text; refers to the Chronic kidney failure subsection overall]\",\"explanation\":\"The chronic kidney failure subsection lists several causes but omits key ones like glomerulonephritis and nephrotic syndrome, which are significant contributors to chronic kidney disease (CKD) and mentioned in the article introduction.\",\"fixedText\":\"Add mentions of glomerulonephritis and nephrotic syndrome as causes of chronic kidney failure.\",\"evidenceSource\":\"NIDDK: Causes of Chronic Kidney Disease in Adults. [](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/causes)\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"\\\"Chronic kidney failure is measured in five stages\\\"\",\"explanation\":\"The five stages are for chronic kidney disease (CKD) overall, not chronic kidney failure specifically. Chronic kidney failure typically denotes stage 5 CKD or end-stage renal disease (ESRD), as per standard medical classification.\",\"fixedText\":\"Revise to: \\\"Chronic kidney disease (CKD) is classified into five stages, calculated using the glomerular filtration rate (GFR).\\\"\",\"evidenceSource\":\"[1], [18], [19], https://www.kidney.org/kidney-topics/stages-chronic-kidney-disease-ckd\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"The paragraph describing stages 1 through 5, ending with citation [35].\",\"explanation\":\"Reference [35] (2008 conference on kidney transplantation for ESRD) mentions stages 3 and 4 in the context of transplant preparation but does not provide a comprehensive description of all five CKD stages or their characteristics.\",\"fixedText\":\"Replace citation [35] with [19] for the stages description, or add a new authoritative source like the National Kidney Foundation guidelines.\",\"evidenceSource\":\"Browsed content of [35]: https://pmc.ncbi.nlm.nih.gov/articles/PMC2390948/\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific GFR thresholds provided for the stages.\",\"explanation\":\"The section explains measurement via GFR but lacks the defining GFR ranges (in mL/min/1.73 mÂ²) for each stage, which are fundamental to the diagnostic classification and calculation method.\",\"fixedText\":\"Add a table or list detailing the five stages with their GFR ranges and brief descriptions, citing an authoritative source.\",\"evidenceSource\":\"[19], https://www.kidney.org/kidney-topics/stages-chronic-kidney-disease-ckd\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"Those with end stage renal failure who undergo haemodialysis have higher risk of spontaneous intra-abdominal bleeding than the general population (21.2%) and [non-occlusive mesenteric ischemia](Intestinal_ischemia \\\"Intestinal ischemia\\\") (18.1%).\",\"explanation\":\"The percentages 21.2% and 18.1% represent the proportions of specific diagnoses (spontaneous intra-abdominal bleeding and non-occlusive mesenteric ischemia, respectively) among hemodialysis patients who presented with acute abdomen and underwent CT imaging in a specific retrospective study, not the overall prevalence or risk in the entire hemodialysis population. This misrepresents the data, exaggerating the incidence; actual overall rates of these events in hemodialysis patients are much lower (e.g., gastrointestinal bleeding incidences reported in other studies are on the order of 4-5% per year or less).\",\"fixedText\":\"Revise to clarify the context: \\\"In a study of hemodialysis patients presenting with acute abdominal conditions who underwent CT, spontaneous intra-abdominal bleeding accounted for 21.2% of cases, and non-occlusive mesenteric ischemia for 18.1%, both higher than in the general population for such presentations.\\\" Or remove specific percentages if not generalizable.\",\"evidenceSource\":\"[38]\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Meanwhile, those undergoing [peritoneal dialysis](Peritoneal_dialysis \\\"Peritoneal dialysis\\\") have a higher chance of developing [peritonitis](Peritonitis \\\"Peritonitis\\\") and [gastrointestinal perforation](Gastrointestinal_perforation \\\"Gastrointestinal perforation\\\"). However, the rate of [acute pancreatitis](Acute_pancreatitis \\\"Acute pancreatitis\\\") does not differ from the general population.[38]\",\"explanation\":\"The cited source [38] is a letter focused primarily on spontaneous renal hemorrhage and briefly mentions peritonitis and gastrointestinal perforation as predominating in PD patients without providing specific data or rates, and notes no difference in acute pancreatitis rates. While directionally correct, the source does not strongly support the claims with evidence, as it is not a comprehensive review; better sourcing from systematic reviews would be ideal, but this is a mismatch for verifiability.\",\"fixedText\":\"Retain the directional claims but add or replace citation with a more authoritative source for PD complications, e.g., a review on peritonitis rates in PD.\",\"evidenceSource\":\"[38]; Cross-verified via external search confirming peritonitis incidence in PD is ~0.3-0.5 episodes/patient-year [](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000905/)\"},{\"criticality\":\"Non-Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific text; overall section scope.\",\"explanation\":\"The section focuses narrowly on gastrointestinal complications related to dialysis modalities, omitting other major complications of kidney failure such as cardiovascular events (e.g., heart failure, arrhythmias due to electrolyte imbalances), mineral bone disease, infections (beyond peritonitis), neuropathy, and increased mortality risk. While some are covered in the introduction, this section could benefit from broader coverage to fulfill its title, including recent data (as of 2025) on overall complication rates.\",\"fixedText\":\"Add subsections or paragraphs on key complication categories with sourced prevalence, e.g., \\\"Cardiovascular complications are the leading cause of death in ESRD, accounting for ~50% of mortality [](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817028/)\\\" ensuring no duplication with intro.\",\"evidenceSource\":\"Introductory section and references [3],[4],[5]; Recent reviews [](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623158/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"\\\"However, this effect does not apply to people with type 2 diabetes.[39]\\\"\",\"explanation\":\"The cited 2015 meta-analysis is outdated; subsequent studies and meta-analyses, including a 2024 systematic review, demonstrate that low-protein diets slow CKD progression and reduce proteinuria in patients with diabetic kidney disease, including type 2 diabetes. This misstates current evidence from KDIGO 2024 guidelines, which recommend low-protein diets generally without excluding type 2 diabetes.\",\"fixedText\":\"Remove the exclusion for type 2 diabetes; revise to state that low-protein diets slow CKD progression in non-dialysis patients, including those with diabetes, citing updated sources.\",\"evidenceSource\":\"[](https://www.mdpi.com/2072-6643/16/11/1687); KDIGO 2024 Guideline\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"A high protein diet from either animal or plant sources appears to have negative effects on kidney function at least in the short term.[41]\\\"\",\"explanation\":\"The cited 2007 review concludes that high-protein vegetable-based diets are likely safe for kidney function in healthy individuals, in contrast to animal-based high-protein diets, which may accelerate deterioration in CKD. The claim inaccurately attributes negative effects to plant sources, misrepresenting the source.\",\"fixedText\":\"Revise to specify that high-protein diets, particularly animal-based, may harm kidney function in CKD; align with KDIGO 2024 recommendation to avoid protein intake \u003e1.3 g/kg/day generally.\",\"evidenceSource\":\"[41]; [](https://pubmed.ncbi.nlm.nih.gov/17383270/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific text; entire \\\"Slowing progression\\\" subsection.\",\"explanation\":\"The subsection omits key evidence-based pharmacological interventions to slow CKD progression, such as renin-angiotensin system inhibitors (RASi), SGLT2 inhibitors, and blood pressure control, which are standard per KDIGO 2024 and critical for preventing ESRD. This creates a knowledge gap in treatment guidance.\",\"fixedText\":\"Add paragraph on pharmacological strategies (e.g., RASi for albuminuria, SGLT2i for CKD with/without diabetes) and blood pressure targets under \\\"Slowing progression\\\".\",\"evidenceSource\":\"KDIGO 2024 Guideline [](https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific text; \\\"Slowing progression\\\" subsection lacks lifestyle details.\",\"explanation\":\"Omits recommendation for physical activity, a key lifestyle intervention to slow progression and improve outcomes in CKD, as per KDIGO 2024 (150 minutes/week moderate-intensity) and mentioned in the article intro. This is a significant gap in comprehensive treatment advice.\",\"fixedText\":\"Add recommendation for regular physical activity (e.g., 150 min/week moderate-intensity) under \\\"Slowing progression\\\".\",\"evidenceSource\":\"KDIGO 2024 Guideline [](https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf)\"}],\"slug\":\"Kidney_failure\",\"title\":\"Kidney failure\",\"content\":\"$1f\",\"description\":\"Kidney failure\\n\\nKidney failure, also known as renal failure or end-stage renal disease (ESRD), is a medical condition in which the kidneys can no longer adequately filter waste products from the...\",\"metadata\":{\"categories\":[\"Renal failure\",\"Acute kidney injury\",\"End-stage renal disease\",\"ESRD\"],\"lastModified\":\"1761552986\",\"contentLength\":\"17686\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"322592\",\"recentViews\":\"322592\",\"dailyAvgViews\":10753.06640625,\"qualityScore\":1,\"lastViewed\":\"1761887003\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761887003565,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Kidney_failure\"],\"queryHash\":\"[\\\"page\\\",\\\"Kidney_failure\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Kidney failure\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Kidney failure, also known as renal failure or end-stage renal disease (ESRD), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels.[2] Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible.[6] Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite,...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"keywords\",\"content\":\"Renal failure, Acute kidney injury, End-stage renal disease, ESRD\"}],[\"$\",\"meta\",\"5\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"6\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"7\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Kidney_failure\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:title\",\"content\":\"Kidney failure\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:description\",\"content\":\"Kidney failure, also known as renal failure or end-stage renal disease (ESRD), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels.[2] Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible.[6] Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite,...\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Kidney_failure\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:image:alt\",\"content\":\"Kidney failure\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"18\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:12.986Z\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:title\",\"content\":\"Kidney failure\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:description\",\"content\":\"Kidney failure, also known as renal failure or end-stage renal disease (ESRD), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels.[2] Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible.[6] Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite,...\"}],[\"$\",\"meta\",\"23\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"24\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"25\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="YzY2YjBkNDktYzRjZi00ODhjLWJlOGEtYjYyZTM5ZGUzMzll">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Kidney_failure\"}]}]\n"])</script></body></html>